Valneva Receives EMA’s Positive CHMP Opinion for its Chikungunya Vaccine
GlobeNewswire
· *If approved, IXCHIQ*^*®** will become the first vaccine available in the EU against the chikungunya virus (CHIKV)*
·..
· *If approved, IXCHIQ*^*®** will become the first vaccine available in the EU against the chikungunya virus (CHIKV)*
·..
Sticks and stones aren’t enough to thwart biological attraction, but sometimes those are the only tools available to pastoralists..
The global AI-Powered Stock Trading Platform market is anticipated to grow from USD 2.15 billion to USD 5.70 billion in 10 years...